REGENXBIO Inc. - Common Stock —— 现金流量表 (NASDAQ:RGNX) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -54.06 M218.88 M-207.49 M-218.41 M-173.13 M-123.96 M -233.78 M 投资活动产生的现金 122.76 M-406.64 M-11.93 M190.94 M103.45 M-15.87 M 9.98 M 融资活动产生的现金 200.21 M195.25 M-28.84 M-34.97 M92.68 M116.77 M 108.93 M 自由现金流 -54.06 M218.88 M-207.49 M-218.41 M-173.13 M-126.38 M -236.4 M

新闻

REGENXBIO Inc. (RGNX) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

REGENXBIO: 'Hold' On RGX-121 CRL MPS II And RGX-202 DMD Results (NASDAQ:RGNX)

REGENXBIO Inc. (RGNX) Q1 2026 Earnings Call Transcript

Regenxbio (RGNX) Reports Q1 Loss, Lags Revenue Estimates

EyePoint (EYPT) Reports Q1 Loss, Tops Revenue Estimates

OCGN Gene Therapy Pipeline: Key 2026-27 Catalysts Ahead

OCGN Gene Therapy Pipeline: Key 2026-27 Catalysts Ahead

Ocugen Stock Outlook: Valuation, Cash Runway and Dilution Risk

Ocugen Stock Outlook: Valuation, Cash Runway and Dilution Risk

Denali Jumps, Pulling Regenxbio Higher, On Early FDA Approval

OCGN Gene-Agnostic Eye Therapy Could Shift Retinal Drug Development

OCGN Gene Therapy Pipeline: 2026-2027 Catalysts To Watch